{
    "abstract": "A replication-deficient chimpanzee adenovirus expressing Ag85A (ChAdOx1.85A) was assessed, both alone and in combination with modified vaccinia Ankara also expressing Ag85A (MVA85A), for its immunogenicity and protective efficacy against a Mycobacterium tuberculosis (M.tb) challenge in mice. Na\u00efve and BCG-primed mice were vaccinated or boosted with ChAdOx1.85A and MVA85A in different combinations. Although intranasally administered ChAdOx1.85A induced strong immune responses in the lungs, it failed to consistently protect against aerosol M.tb challenge. In contrast, ChAdOx1.85A followed by MVA85A administered either mucosally or systemically, induced strong immune responses and was able to improve the protective efficacy of BCG. This vaccination regime has consistently shown superior protection over BCG alone and should be evaluated further.",
    "author_highlights": [
        {
            "endOffset": 13928,
            "sentence": "Intranasal immunisation with ChAdOx1.85A induces strong T-cell responses.",
            "startOffset": 13855
        },
        {
            "endOffset": 14015,
            "sentence": "ChAdOx1.85A boosted with MVA85A significantly improves the protective efficacy of BCG.",
            "startOffset": 13929
        },
        {
            "endOffset": 14090,
            "sentence": "MVA85A boost is protective both after mucosal and systemic administration.",
            "startOffset": 14016
        }
    ],
    "bib_entries": {
        "bib0200": null,
        "bib0205": {
            "authors": [
                {
                    "first": "Laura C.",
                    "initial": "L.C.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Vinod K.",
                    "initial": "V.K.",
                    "last": "Diwan"
                },
                {
                    "first": "Jeremy G.",
                    "initial": "J.G.",
                    "last": "Wheeler"
                }
            ],
            "doi": "10.1093/ije/22.6.1154",
            "firstpage": "1154",
            "issn": "03005771",
            "lastpage": "1158",
            "pmid": "8144299",
            "pub_year": 1993,
            "title": "Protective effect of bcg against tuberculous meningitis and miliary tuberculosis: A meta-analysis",
            "volume": "22"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                },
                {
                    "first": "Stefan H.E.",
                    "initial": "S.H.E.",
                    "last": "Kaufmann"
                }
            ],
            "doi": "10.1101/cshperspect.a018523",
            "issn": "21571422",
            "pmid": "24890836",
            "pub_year": 2014,
            "title": "Novel vaccination strategies against tuberculosis",
            "volume": "4"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "Leander",
                    "initial": "L.",
                    "last": "Grode"
                },
                {
                    "first": "Christian A.",
                    "initial": "C.A.",
                    "last": "Ganoza"
                },
                {
                    "first": "Christiane",
                    "initial": "C.",
                    "last": "Brohm"
                },
                {
                    "first": "January",
                    "initial": "J.",
                    "last": "Weiner"
                },
                {
                    "first": "Bernd",
                    "initial": "B.",
                    "last": "Eisele"
                },
                {
                    "first": "Stefan H.E.",
                    "initial": "S.H.E.",
                    "last": "Kaufmann"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.12.053",
            "firstpage": "1340",
            "issn": "0264410X",
            "lastpage": "1348",
            "pmid": "23290835",
            "pub_year": 2013,
            "title": "Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial",
            "volume": "31"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "Ainhoa",
                    "initial": "A.",
                    "last": "Arbues"
                },
                {
                    "first": "Juan I.",
                    "initial": "J.I.",
                    "last": "Aguilo"
                },
                {
                    "first": "Jesus",
                    "initial": "J.",
                    "last": "Gonzalo-Asensio"
                },
                {
                    "first": "Dessislava",
                    "initial": "D.",
                    "last": "Marinova"
                },
                {
                    "first": "Santiago",
                    "initial": "S.",
                    "last": "Uranga"
                },
                {
                    "first": "Eugenia",
                    "initial": "E.",
                    "last": "Puentes"
                },
                {
                    "first": "Conchita",
                    "initial": "C.",
                    "last": "Fernandez"
                },
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Parra"
                },
                {
                    "first": "Pere Joan",
                    "initial": "P.J.",
                    "last": "Cardona"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Vilaplana"
                },
                {
                    "first": "Vicente",
                    "initial": "V.",
                    "last": "Ausina"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Williams"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Clark"
                },
                {
                    "first": "Wladimir",
                    "initial": "W.",
                    "last": "Malaga"
                },
                {
                    "first": "Christophe",
                    "initial": "C.",
                    "last": "Guilhot"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Gicquel"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Martin"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.07.051",
            "firstpage": "4867",
            "issn": "0264410X",
            "lastpage": "4873",
            "pmid": "23965219",
            "pub_year": 2013,
            "title": "Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials",
            "volume": "31"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Claus",
                    "initial": "C.",
                    "last": "Aagaard"
                },
                {
                    "first": "Truc",
                    "initial": "T.",
                    "last": "Hoang"
                },
                {
                    "first": "Jes",
                    "initial": "J.",
                    "last": "Dietrich"
                },
                {
                    "first": "Pere Joan",
                    "initial": "P.J.",
                    "last": "Cardona"
                },
                {
                    "first": "Angelo",
                    "initial": "A.",
                    "last": "Izzo"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Dolganov"
                },
                {
                    "first": "Gary K.",
                    "initial": "G.K.",
                    "last": "Schoolnik"
                },
                {
                    "first": "Joseph P.",
                    "initial": "J.P.",
                    "last": "Cassidy"
                },
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "Billeskov"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                }
            ],
            "doi": "10.1038/nm.2285",
            "firstpage": "189",
            "issn": "10788956",
            "lastpage": "195",
            "pmid": "21258338",
            "pub_year": 2011,
            "title": "A multistage tuberculosis vaccine that confers efficient protection before and after exposure",
            "volume": "17"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Cheryl L.",
                    "initial": "C.L.",
                    "last": "Day"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Tameris"
                },
                {
                    "first": "Nazma",
                    "initial": "N.",
                    "last": "Mansoor"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Van Rooyen"
                },
                {
                    "first": "Marwou",
                    "initial": "M.",
                    "last": "De Kock"
                },
                {
                    "first": "Hennie",
                    "initial": "H.",
                    "last": "Geldenhuys"
                },
                {
                    "first": "Mzwandile",
                    "initial": "M.",
                    "last": "Erasmus"
                },
                {
                    "first": "Lebohang",
                    "initial": "L.",
                    "last": "Makhethe"
                },
                {
                    "first": "E. Jane",
                    "initial": "E.J.",
                    "last": "Hughes"
                },
                {
                    "first": "Sebastian",
                    "initial": "S.",
                    "last": "Gelderbloem"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Bollaerts"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Bourguignon"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen."
                },
                {
                    "first": "Marie Ange",
                    "initial": "M.A.",
                    "last": "Demoitie"
                },
                {
                    "first": "Pascal",
                    "initial": "P.",
                    "last": "Mettens"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Jerald C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Hawkridge"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "D. Hussey"
                },
                {
                    "first": "Hassan",
                    "initial": "H.",
                    "last": "Mahomed"
                },
                {
                    "first": "Opokua",
                    "initial": "O.",
                    "last": "Ofori-Anyinam"
                },
                {
                    "first": "Willem A.",
                    "initial": "W.A.",
                    "last": "Hanekom"
                }
            ],
            "doi": "10.1164/rccm.201208-1385OC",
            "firstpage": "492",
            "issn": "1073449X",
            "lastpage": "502",
            "pmid": "23306546",
            "pub_year": 2013,
            "title": "Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults",
            "volume": "188"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Claus",
                    "initial": "C.",
                    "last": "Aagaard"
                },
                {
                    "first": "Truc Thi Kim Thanh",
                    "initial": "T.T.K.T.",
                    "last": "Hoang"
                },
                {
                    "first": "Angelo",
                    "initial": "A.",
                    "last": "Izzo"
                },
                {
                    "first": "Rolf",
                    "initial": "R.",
                    "last": "Billeskov"
                },
                {
                    "first": "Jo Lynn",
                    "initial": "J.L.",
                    "last": "Troudt"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Arnett"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Keyser"
                },
                {
                    "first": "Tara",
                    "initial": "T.",
                    "last": "Elvang"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                },
                {
                    "first": "Jes",
                    "initial": "J.",
                    "last": "Dietrich"
                }
            ],
            "doi": "10.1371/journal.pone.0005930",
            "issn": "19326203",
            "pmid": "19529771",
            "pub_year": 2009,
            "title": "Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31\u00ae against Mycobacterium tuberculosis is highly dependent on the antigen dose",
            "volume": "4"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "Sylvie",
                    "initial": "S.",
                    "last": "Bertholet"
                },
                {
                    "first": "Gregory C.",
                    "initial": "G.C.",
                    "last": "Ireton"
                },
                {
                    "first": "Diane J.",
                    "initial": "D.J.",
                    "last": "Ordway"
                },
                {
                    "first": "Hillarie Plessner",
                    "initial": "H.P.",
                    "last": "Windish"
                },
                {
                    "first": "Samuel O.",
                    "initial": "S.O.",
                    "last": "Pine"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Kahn"
                },
                {
                    "first": "Tony",
                    "initial": "T.",
                    "last": "Phan"
                },
                {
                    "first": "Ian M.",
                    "initial": "I.M.",
                    "last": "Orme"
                },
                {
                    "first": "Thomas S.",
                    "initial": "T.S.",
                    "last": "Vedvick"
                },
                {
                    "first": "Susan L.",
                    "initial": "S.L.",
                    "last": "Baldwin"
                },
                {
                    "first": "Rhea N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1126/scitranslmed.3001094",
            "issn": "19466234",
            "pmid": "20944089",
            "pub_year": 2010,
            "title": "A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant mycobacterium tuberculosis",
            "volume": "2"
        },
        "bib0245": null,
        "bib0250": {
            "authors": [
                {
                    "first": "Birahim Pierre",
                    "initial": "B.P.",
                    "last": "Ndiaye"
                },
                {
                    "first": "Friedrich",
                    "initial": "F.",
                    "last": "Thienemann"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Ota"
                },
                {
                    "first": "Bernard S.",
                    "initial": "B.S.",
                    "last": "Landry"
                },
                {
                    "first": "Makhtar",
                    "initial": "M.",
                    "last": "Camara"
                },
                {
                    "first": "Siry",
                    "initial": "S.",
                    "last": "Di\u00e8ye"
                },
                {
                    "first": "Tandakha Ndiaye",
                    "initial": "T.N.",
                    "last": "Dieye"
                },
                {
                    "first": "Hanif",
                    "initial": "H.",
                    "last": "Esmail"
                },
                {
                    "first": "Rene",
                    "initial": "R.",
                    "last": "Goliath"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Vanessa",
                    "initial": "V.",
                    "last": "January"
                },
                {
                    "first": "Ibrahima",
                    "initial": "I.",
                    "last": "Ndiaye"
                },
                {
                    "first": "Tolu",
                    "initial": "T.",
                    "last": "Oni"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Raine"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Romano"
                },
                {
                    "first": "Iman",
                    "initial": "I.",
                    "last": "Satti"
                },
                {
                    "first": "Sharon",
                    "initial": "S.",
                    "last": "Sutton"
                },
                {
                    "first": "Aminata",
                    "initial": "A.",
                    "last": "Thiam"
                },
                {
                    "first": "Katalin A.",
                    "initial": "K.A.",
                    "last": "Wilkinson"
                },
                {
                    "first": "Souleymane",
                    "initial": "S.",
                    "last": "Mboup"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Wilkinson"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1016/S2213-2600(15)00037-5",
            "firstpage": "190",
            "issn": "22132600",
            "lastpage": "200",
            "pmid": "25726088",
            "pub_year": 2015,
            "title": "Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: A randomised, placebo-controlled, phase 2 trial",
            "volume": "3"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "Gavin John",
                    "initial": "G.J.",
                    "last": "Churchyard"
                },
                {
                    "first": "Margaret Ann",
                    "initial": "M.A.",
                    "last": "Snowden"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Hokey"
                },
                {
                    "first": "Veerabadran",
                    "initial": "V.",
                    "last": "Dheenadhayalan"
                },
                {
                    "first": "J. Bruce",
                    "initial": "J.B.",
                    "last": "McClain"
                },
                {
                    "first": "Macaya",
                    "initial": "M.",
                    "last": "Douoguih"
                },
                {
                    "first": "Maria Grazia",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Jerry",
                    "initial": "J.",
                    "last": "Sadoff"
                },
                {
                    "first": "Bernard",
                    "initial": "B.",
                    "last": "Landry"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.02.004",
            "firstpage": "1890",
            "issn": "0264410X",
            "lastpage": "1896",
            "pmid": "25698492",
            "pub_year": 2015,
            "title": "The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3",
            "volume": "33"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "Smaill"
                },
                {
                    "first": "Mangalakumari",
                    "initial": "M.",
                    "last": "Jeyanathan"
                },
                {
                    "first": "Marek",
                    "initial": "M.",
                    "last": "Smieja"
                },
                {
                    "first": "Maria Fe",
                    "initial": "M.F.",
                    "last": "Medina"
                },
                {
                    "first": "Niroshan",
                    "initial": "N.",
                    "last": "Thanthrige-Don"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Zganiacz"
                },
                {
                    "first": "Cindy",
                    "initial": "C.",
                    "last": "Yin"
                },
                {
                    "first": "Armando",
                    "initial": "A.",
                    "last": "Heriazon"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Damjanovic"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Puri"
                },
                {
                    "first": "Jemila",
                    "initial": "J.",
                    "last": "Hamid"
                },
                {
                    "first": "Feng",
                    "initial": "F.",
                    "last": "Xie"
                },
                {
                    "first": "Ronan",
                    "initial": "R.",
                    "last": "Foley"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Bramson"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Gauldie"
                },
                {
                    "first": "Zhou",
                    "initial": "Z.",
                    "last": "Xing"
                }
            ],
            "doi": "10.1126/scitranslmed.3006843",
            "issn": "19466234",
            "pmid": "24089406",
            "pub_year": 2013,
            "title": "A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity",
            "volume": "5"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "Zita Rose Manjaly",
                    "initial": "Z.R.M.",
                    "last": "Thomas"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1093/trstmh/tru206",
            "firstpage": "175",
            "issn": "00359203",
            "lastpage": "181",
            "pmid": "25636950",
            "pub_year": 2014,
            "title": "Aerosol immunisation for TB: Matching route of vaccination to route of infection",
            "volume": "109"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Thorson"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Stokes"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Santosuosso"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Zganiacz"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Hitt"
                },
                {
                    "first": "Zhou",
                    "initial": "Z.",
                    "last": "Xing"
                }
            ],
            "doi": "10.4049/jimmunol.173.10.6357",
            "firstpage": "6357",
            "issn": "00221767",
            "lastpage": "6365",
            "pmid": "15528375",
            "pub_year": 2004,
            "title": "Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis",
            "volume": "173"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "Nilu P.",
                    "initial": "N.P.",
                    "last": "Goonetilleke"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                },
                {
                    "first": "Carolyn M.",
                    "initial": "C.M.",
                    "last": "Hannan"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Anderson"
                },
                {
                    "first": "Roger H.",
                    "initial": "R.H.",
                    "last": "Brookes"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.4049/jimmunol.171.3.1602",
            "firstpage": "1602",
            "issn": "00221767",
            "lastpage": "1609",
            "pmid": "12874255",
            "pub_year": 2003,
            "title": "Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara",
            "volume": "171"
        },
        "bib0280": {
            "authors": [
                {
                    "first": "Iman",
                    "initial": "I.",
                    "last": "Satti"
                },
                {
                    "first": "Joel",
                    "initial": "J.",
                    "last": "Meyer"
                },
                {
                    "first": "Stephanie A.",
                    "initial": "S.A.",
                    "last": "Harris"
                },
                {
                    "first": "Zita Rose Manjaly",
                    "initial": "Z.R.M.",
                    "last": "Thomas"
                },
                {
                    "first": "Kristin",
                    "initial": "K.",
                    "last": "Griffiths"
                },
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Antrobus"
                },
                {
                    "first": "Rosalind",
                    "initial": "R.",
                    "last": "Rowland"
                },
                {
                    "first": "Raquel Lopez",
                    "initial": "R.L.",
                    "last": "Ramon"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Smith"
                },
                {
                    "first": "Sharon",
                    "initial": "S.",
                    "last": "Sheehan"
                },
                {
                    "first": "Henry",
                    "initial": "H.",
                    "last": "Bettinson"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1016/S1473-3099(14)70845-X",
            "firstpage": "939",
            "issn": "14733099",
            "lastpage": "946",
            "pmid": "25151225",
            "pub_year": 2014,
            "title": "Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial",
            "volume": "14"
        },
        "bib0285": {
            "authors": [
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "G\u00f6ran",
                    "initial": "G.",
                    "last": "Wadell"
                },
                {
                    "first": "Kalifa",
                    "initial": "K.",
                    "last": "Bojang"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                }
            ],
            "doi": "10.1371/journal.pone.0040385",
            "issn": "19326203",
            "pmid": "22808149",
            "pub_year": 2012,
            "title": "A novel chimpanzee adenovirus vector with low human seroprevalence: Improved systems for vector derivation and comparative immunogenicity",
            "volume": "7"
        },
        "bib0290": {
            "authors": [
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Tatsis"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Tesema"
                },
                {
                    "first": "E. R.",
                    "initial": "E.R.",
                    "last": "Robinson"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Giles-Davis"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "McCoy"
                },
                {
                    "first": "G. P.",
                    "initial": "G.P.",
                    "last": "Gao"
                },
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Wilson"
                },
                {
                    "first": "H. C.J.",
                    "initial": "H.C.J.",
                    "last": "Ertl"
                }
            ],
            "doi": "10.1038/sj.gt.3302675",
            "firstpage": "421",
            "issn": "09697128",
            "lastpage": "429",
            "pmid": "16319951",
            "pub_year": 2006,
            "title": "Chimpanzee-origin adenovirus vectors as vaccine carriers",
            "volume": "13"
        },
        "bib0295": {
            "authors": [
                {
                    "first": "Zhiquan",
                    "initial": "Z.",
                    "last": "Xiang"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Cun"
                },
                {
                    "first": "Wei",
                    "initial": "W.",
                    "last": "Yang"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Ellenberg"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Switzer"
                },
                {
                    "first": "Marcia L.",
                    "initial": "M.L.",
                    "last": "Kalish"
                },
                {
                    "first": "Hildegund C.J.",
                    "initial": "H.C.J.",
                    "last": "Ertl"
                }
            ],
            "doi": "10.3201/eid1210.060078",
            "firstpage": "1596",
            "issn": "10806040",
            "lastpage": "1599",
            "pmid": "17176582",
            "pub_year": 2006,
            "title": "Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa",
            "volume": "12"
        },
        "bib0300": {
            "authors": [
                {
                    "first": "M. Juliana",
                    "initial": "M.J.",
                    "last": "McElrath"
                },
                {
                    "first": "Stephen C.",
                    "initial": "S.C.",
                    "last": "De Rosa"
                },
                {
                    "first": "Zoe",
                    "initial": "Z.",
                    "last": "Moodie"
                },
                {
                    "first": "Sheri",
                    "initial": "S.",
                    "last": "Dubey"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Kierstead"
                },
                {
                    "first": "Holly",
                    "initial": "H.",
                    "last": "Janes"
                },
                {
                    "first": "Olivier D.",
                    "initial": "O.D.",
                    "last": "Defawe"
                },
                {
                    "first": "Donald K.",
                    "initial": "D.K.",
                    "last": "Carter"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Hural"
                },
                {
                    "first": "Rama",
                    "initial": "R.",
                    "last": "Akondy"
                },
                {
                    "first": "Susan P.",
                    "initial": "S.P.",
                    "last": "Buchbinder"
                },
                {
                    "first": "Michael N.",
                    "initial": "M.N.",
                    "last": "Robertson"
                },
                {
                    "first": "Devan V.",
                    "initial": "D.V.",
                    "last": "Mehrotra"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Self"
                },
                {
                    "first": "Lawrence",
                    "initial": "L.",
                    "last": "Corey"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Shiver"
                },
                {
                    "first": "Danilo R.",
                    "initial": "D.R.",
                    "last": "Casimiro"
                }
            ],
            "doi": "10.1016/S0140-6736(08)61592-5",
            "firstpage": "1894",
            "issn": "01406736",
            "lastpage": "1905",
            "pmid": "19012957",
            "pub_year": 2008,
            "title": "HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis",
            "volume": "372"
        },
        "bib0305": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Dudareva"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Andrews"
                },
                {
                    "first": "S. C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Bejon"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Marsh"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Mwacharo"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Kai"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "A. V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.03.080",
            "firstpage": "3501",
            "issn": "0264410X",
            "lastpage": "3504",
            "pmid": "19464527",
            "pub_year": 2009,
            "title": "Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy",
            "volume": "27"
        },
        "bib0310": {
            "authors": [
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Scriba"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Tameris"
                },
                {
                    "first": "Nazma",
                    "initial": "N.",
                    "last": "Mansoor"
                },
                {
                    "first": "Erica",
                    "initial": "E.",
                    "last": "Smit"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Van Der Merwe"
                },
                {
                    "first": "Fatima",
                    "initial": "F.",
                    "last": "Isaacs"
                },
                {
                    "first": "Alana",
                    "initial": "A.",
                    "last": "Keyser"
                },
                {
                    "first": "Sizulu",
                    "initial": "S.",
                    "last": "Moyo"
                },
                {
                    "first": "Nathaniel",
                    "initial": "N.",
                    "last": "Brittain"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Lawrie"
                },
                {
                    "first": "Sebastian",
                    "initial": "S.",
                    "last": "Gelderbloem"
                },
                {
                    "first": "Ashley",
                    "initial": "A.",
                    "last": "Veldsman"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Hatherill"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Hawkridge"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Gregory D.",
                    "initial": "G.D.",
                    "last": "Hussey"
                },
                {
                    "first": "Hassan",
                    "initial": "H.",
                    "last": "Mahomed"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                },
                {
                    "first": "Willem A.",
                    "initial": "W.A.",
                    "last": "Hanekom"
                }
            ],
            "doi": "10.1002/eji.200939754",
            "firstpage": "279",
            "issn": "00142980",
            "lastpage": "290",
            "pmid": "20017188",
            "pub_year": 2010,
            "title": "Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells",
            "volume": "40"
        },
        "bib0315": {
            "authors": [
                {
                    "first": "Brian",
                    "initial": "B.",
                    "last": "Abel"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Tameris"
                },
                {
                    "first": "Nazma",
                    "initial": "N.",
                    "last": "Mansoor"
                },
                {
                    "first": "Sebastian",
                    "initial": "S.",
                    "last": "Gelderbloem"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Hughes"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Abrahams"
                },
                {
                    "first": "Lebohang",
                    "initial": "L.",
                    "last": "Makhethe"
                },
                {
                    "first": "Mzwandile",
                    "initial": "M.",
                    "last": "Erasmus"
                },
                {
                    "first": "Marwou",
                    "initial": "M.",
                    "last": "De Kock"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Van Der Merwe"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Hawkridge"
                },
                {
                    "first": "Ashley",
                    "initial": "A.",
                    "last": "Veldsman"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Hatherill"
                },
                {
                    "first": "Giulia",
                    "initial": "G.",
                    "last": "Schirru"
                },
                {
                    "first": "Maria Grazia",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Jenny",
                    "initial": "J.",
                    "last": "Hendriks"
                },
                {
                    "first": "Gerrit Jan",
                    "initial": "G.J.",
                    "last": "Weverling"
                },
                {
                    "first": "Jaap",
                    "initial": "J.",
                    "last": "Goudsmit"
                },
                {
                    "first": "Donata",
                    "initial": "D.",
                    "last": "Sizemore"
                },
                {
                    "first": "J. Bruce",
                    "initial": "J.B.",
                    "last": "McClain"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "Goetz"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Gearhart"
                },
                {
                    "first": "Hassan",
                    "initial": "H.",
                    "last": "Mahomed"
                },
                {
                    "first": "Gregory D.",
                    "initial": "G.D.",
                    "last": "Hussey"
                },
                {
                    "first": "Jerald C.",
                    "initial": "J.C.",
                    "last": "Sadoff"
                },
                {
                    "first": "Willem A.",
                    "initial": "W.A.",
                    "last": "Hanekom"
                }
            ],
            "doi": "10.1164/rccm.200910-1484OC",
            "firstpage": "1407",
            "issn": "1073449X",
            "lastpage": "1417",
            "pmid": "20167847",
            "pub_year": 2010,
            "title": "The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+and CD8+ T cells in adults",
            "volume": "181"
        },
        "bib0320": {
            "authors": [
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Efrain",
                    "initial": "E.",
                    "last": "Guzman"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Bryan",
                    "initial": "B.",
                    "last": "Charleston"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.01.042",
            "firstpage": "1121",
            "issn": "0264410X",
            "lastpage": "1128",
            "pmid": "25629523",
            "pub_year": 2015,
            "title": "The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species",
            "volume": "33"
        },
        "bib0325": {
            "authors": [
                {
                    "first": "S. F.",
                    "initial": "S.F.",
                    "last": "Farina"
                },
                {
                    "first": "G. P.",
                    "initial": "G.P.",
                    "last": "Gao"
                },
                {
                    "first": "Z. Q.",
                    "initial": "Z.Q.",
                    "last": "Xiang"
                },
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Rux"
                },
                {
                    "first": "R. M.",
                    "initial": "R.M.",
                    "last": "Burnett"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Alvira"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Marsh"
                },
                {
                    "first": "H. C.J.",
                    "initial": "H.C.J.",
                    "last": "Ertl"
                },
                {
                    "first": "J. M.",
                    "initial": "J.M.",
                    "last": "Wilson"
                }
            ],
            "doi": "10.1128/JVI.75.23.11603-11613.2001",
            "firstpage": "11603",
            "issn": "0022538X",
            "lastpage": "11613",
            "pmid": "11689642",
            "pub_year": 2001,
            "title": "Replication-defective vector based on a chimpanzee adenovirus",
            "volume": "75"
        },
        "bib0330": {
            "authors": [
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Santosuosso"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "McCormick"
                },
                {
                    "first": "Xizhong",
                    "initial": "X.",
                    "last": "Zhang"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Zganiacz"
                },
                {
                    "first": "Zhou",
                    "initial": "Z.",
                    "last": "Xing"
                }
            ],
            "doi": "10.1128/IAI.00517-06",
            "firstpage": "4634",
            "issn": "00199567",
            "lastpage": "4643",
            "pmid": "16861651",
            "pub_year": 2006,
            "title": "Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis",
            "volume": "74"
        },
        "bib0335": {
            "authors": [
                {
                    "first": "Edward O.",
                    "initial": "E.O.",
                    "last": "Ronan"
                },
                {
                    "first": "Lian Ni",
                    "initial": "L.N.",
                    "last": "Lee"
                },
                {
                    "first": "Peter C.L.",
                    "initial": "P.C.L.",
                    "last": "Beverley"
                },
                {
                    "first": "Elma Z.",
                    "initial": "E.Z.",
                    "last": "Tchilian"
                }
            ],
            "doi": "10.1371/journal.pone.0008235",
            "issn": "19326203",
            "pmid": "20011050",
            "pub_year": 2009,
            "title": "Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of mycobacterium tuberculosis after infection",
            "volume": "4"
        },
        "bib0340": {
            "authors": [
                {
                    "first": "Divey",
                    "initial": "D.",
                    "last": "Saini"
                },
                {
                    "first": "Gregory W.",
                    "initial": "G.W.",
                    "last": "Hopkins"
                },
                {
                    "first": "Ching Ju",
                    "initial": "C.J.",
                    "last": "Chen"
                },
                {
                    "first": "Sarah A.",
                    "initial": "S.A.",
                    "last": "Seay"
                },
                {
                    "first": "Eva M.",
                    "initial": "E.M.",
                    "last": "Click"
                },
                {
                    "first": "Sunhee",
                    "initial": "S.",
                    "last": "Lee"
                },
                {
                    "first": "Justin M.",
                    "initial": "J.M.",
                    "last": "Hartings"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Frothingham"
                }
            ],
            "doi": "10.1016/j.vascn.2010.09.002",
            "firstpage": "143",
            "issn": "10568719",
            "lastpage": "149",
            "pmid": "20849964",
            "pub_year": 2011,
            "title": "Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development",
            "volume": "63"
        },
        "bib0345": {
            "authors": [
                {
                    "first": "Richard James",
                    "initial": "R.J.",
                    "last": "Thomas"
                }
            ],
            "doi": "10.4161/viru.27172",
            "issn": "21505594",
            "pmid": "24225380",
            "pub_year": 2013,
            "title": "Particle size and pathogenicity in the respiratory tract",
            "volume": "4"
        },
        "bib0350": {
            "authors": [
                {
                    "first": "Zhou",
                    "initial": "Z.",
                    "last": "Xing"
                },
                {
                    "first": "Christine T.",
                    "initial": "C.T.",
                    "last": "McFarland"
                },
                {
                    "first": "Jean Michel",
                    "initial": "J.M.",
                    "last": "Sallenave"
                },
                {
                    "first": "Angelo",
                    "initial": "A.",
                    "last": "Izzo"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "David N.",
                    "initial": "D.N.",
                    "last": "McMurray"
                }
            ],
            "doi": "10.1371/journal.pone.0005856",
            "issn": "19326203",
            "pmid": "19516906",
            "pub_year": 2009,
            "title": "Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis",
            "volume": "4"
        },
        "bib0355": {
            "authors": [
                {
                    "first": "Gareth",
                    "initial": "G.",
                    "last": "Betts"
                },
                {
                    "first": "Hazel",
                    "initial": "H.",
                    "last": "Poyntz"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Stylianou"
                },
                {
                    "first": "Arturo",
                    "initial": "A.",
                    "last": "Reyes-Sandoval"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Cottingham"
                },
                {
                    "first": "Adrian",
                    "initial": "A.",
                    "last": "Hill"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "McShane"
                }
            ],
            "doi": "10.1371/journal.pone.0050447",
            "issn": "19326203",
            "pmid": "23284637",
            "pub_year": 2012,
            "title": "Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection",
            "volume": "7"
        },
        "bib0360": {
            "authors": [
                {
                    "first": "Geraldine A.",
                    "initial": "G.A.",
                    "last": "O'Hara"
                },
                {
                    "first": "Christopher J.A.",
                    "initial": "C.J.A.",
                    "last": "Duncan"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Sean C.",
                    "initial": "S.C.",
                    "last": "Elias"
                },
                {
                    "first": "Fenella D.",
                    "initial": "F.D.",
                    "last": "Halstead"
                },
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "Arturo",
                    "initial": "A.",
                    "last": "Reyes-Sandoval"
                },
                {
                    "first": "Prudence",
                    "initial": "P.",
                    "last": "Bird"
                },
                {
                    "first": "Rosalind",
                    "initial": "R.",
                    "last": "Rowland"
                },
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Sheehy"
                },
                {
                    "first": "Ian D.",
                    "initial": "I.D.",
                    "last": "Poulton"
                },
                {
                    "first": "Claire",
                    "initial": "C.",
                    "last": "Hutchings"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Todryk"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Andrews"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Folgori"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Loredana",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1093/infdis/jir850",
            "firstpage": "772",
            "issn": "00221899",
            "lastpage": "781",
            "pmid": "22275401",
            "pub_year": 2012,
            "title": "Clinical assessment of a recombinant simian adenovirus ChAd63: A potent new vaccine vector",
            "volume": "205"
        },
        "bib0365": {
            "authors": [
                {
                    "first": "Eoghan",
                    "initial": "E.",
                    "last": "De Barra"
                },
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Hodgson"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Carly M.",
                    "initial": "C.M.",
                    "last": "Bliss"
                },
                {
                    "first": "Kerrie",
                    "initial": "K.",
                    "last": "Hennigan"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Collins"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Samuel J.",
                    "initial": "S.J.",
                    "last": "McConkey"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1371/journal.pone.0115161",
            "issn": "19326203",
            "pmid": "25522180",
            "pub_year": 2014,
            "title": "A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS",
            "volume": "9"
        },
        "bib0370": {
            "authors": [
                {
                    "first": "Ian M.",
                    "initial": "I.M.",
                    "last": "Orme"
                }
            ],
            "doi": "10.1016/j.tube.2010.06.002",
            "firstpage": "329",
            "issn": "14729792",
            "lastpage": "332",
            "pmid": "20659816",
            "pub_year": 2010,
            "title": "The Achilles heel of BCG",
            "volume": "90"
        },
        "bib0375": {
            "authors": [
                {
                    "first": "Marcela",
                    "initial": "M.",
                    "last": "Henao-Tamayo"
                },
                {
                    "first": "Diane J.",
                    "initial": "D.J.",
                    "last": "Ordway"
                },
                {
                    "first": "Ian M.",
                    "initial": "I.M.",
                    "last": "Orme"
                }
            ],
            "doi": "10.1016/j.tube.2014.05.001",
            "firstpage": "455",
            "issn": "14729792",
            "lastpage": "461",
            "pmid": "24993316",
            "pub_year": 2014,
            "title": "Memory T cell subsets in tuberculosis: What should we be targeting?",
            "volume": "94"
        },
        "bib0380": {
            "authors": [
                {
                    "first": "Rocky",
                    "initial": "R.",
                    "last": "Lai"
                },
                {
                    "first": "Sam",
                    "initial": "S.",
                    "last": "Afkhami"
                },
                {
                    "first": "Siamak",
                    "initial": "S.",
                    "last": "Haddadi"
                },
                {
                    "first": "Mangalakumari",
                    "initial": "M.",
                    "last": "Jeyanathan"
                },
                {
                    "first": "Zhou",
                    "initial": "Z.",
                    "last": "Xing"
                }
            ],
            "doi": "10.1183/16000617.00002515",
            "firstpage": "356",
            "issn": "09059180",
            "lastpage": "360",
            "pmid": "26028646",
            "pub_year": 2015,
            "title": "Mucosal immunity and novel tuberculosis vaccine strategies: Route of immunisationdetermined T-cell homing to restricted lung mucosal compartments",
            "volume": "24"
        },
        "bib0385": {
            "authors": [
                {
                    "first": "Richard D.",
                    "initial": "R.D.",
                    "last": "Antrobus"
                },
                {
                    "first": "Lynda",
                    "initial": "L.",
                    "last": "Coughlan"
                },
                {
                    "first": "Tamara K.",
                    "initial": "T.K.",
                    "last": "Berthoud"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Dicks"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1038/mt.2013.284",
            "firstpage": "668",
            "issn": "15250016",
            "lastpage": "674",
            "pmid": "24374965",
            "pub_year": 2014,
            "title": "Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens",
            "volume": "22"
        },
        "bib0390": {
            "authors": [
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Geraldine A.",
                    "initial": "G.A.",
                    "last": "O'Hara"
                },
                {
                    "first": "Christopher J.A.",
                    "initial": "C.J.A.",
                    "last": "Duncan"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Sheehy"
                },
                {
                    "first": "Arturo",
                    "initial": "A.",
                    "last": "Reyes-Sandoval"
                },
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "Sean C.",
                    "initial": "S.C.",
                    "last": "Elias"
                },
                {
                    "first": "Fenella D.",
                    "initial": "F.D.",
                    "last": "Halstead"
                },
                {
                    "first": "Rhea J.",
                    "initial": "R.J.",
                    "last": "Longley"
                },
                {
                    "first": "Rosalind",
                    "initial": "R.",
                    "last": "Rowland"
                },
                {
                    "first": "Ian D.",
                    "initial": "I.D.",
                    "last": "Poulton"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                },
                {
                    "first": "Andrew M.",
                    "initial": "A.M.",
                    "last": "Blagborough"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Williams"
                },
                {
                    "first": "Loredana",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Folgori"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Robert E.",
                    "initial": "R.E.",
                    "last": "Sinden"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1038/ncomms3836",
            "issn": "20411723",
            "pmid": "24284865",
            "pub_year": 2013,
            "title": "Protective CD8 + T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation",
            "volume": "4"
        }
    },
    "body_text": [
        {
            "endOffset": 22827,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "Since ChAdOx1.85A induced strong CD8+ T cell responses we decided to use MVA85A, a strong inducer of CD4+ responses, as a booster vaccine.",
            "startOffset": 22689,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 24752,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "No vaccine regime was able to induce strong CD4+ responses in the spleen.",
            "startOffset": 24679,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 16611,
            "parents": [],
            "secId": "sec0005",
            "sentence": "As TB is primarily initiated by the inhalation of aerosol droplets containing Mycobacterium tuberculosis (M.tb) establishing an infection in the lung, a vaccine that induces a local lung immune response could be advantageous.",
            "startOffset": 16386,
            "title": "Introduction"
        },
        {
            "endOffset": 33378,
            "parents": [],
            "refoffsets": {
                "bib0370": {
                    "endOffset": 33377,
                    "startOffset": 33370
                },
                "bib0375": {
                    "endOffset": 33377,
                    "startOffset": 33370
                }
            },
            "secId": "sec0070",
            "sentence": "A possible reason for this efficacy could be the ability of C\u2013M to induce central memory responses which are not induced by BCG vaccination and might be needed for durable protection [35,36].",
            "startOffset": 33187,
            "title": "Discussion"
        },
        {
            "endOffset": 21920,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "The percentages of cytokine-secreting CD4+ cells induced were much lower, with only TNF\u03b1 and IL2 significantly higher in the vaccinated compared to na\u00efve and BCG control group (p < 0.05) (Fig. 1C).",
            "startOffset": 21723,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 30705,
            "parents": [],
            "secId": "sec0070",
            "sentence": "This system is perhaps more similar to more stringent animal species e.g. the guinea pig.",
            "startOffset": 30616,
            "title": "Discussion"
        },
        {
            "endOffset": 26101,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0060",
            "sentence": "In the first experiment (MVA85A administered i.d.) all the BCG-primed groups had significantly lower bacterial load in the lungs compared to na\u00efve mice and to mice that were not BCG primed (p < 0.001) (Fig. 4B).",
            "startOffset": 25890,
            "title": "Optimisation of vaccine regime: protection studies"
        },
        {
            "endOffset": 27219,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "Control groups included BCG alone or BCG followed by C. Protective efficacy and immunogenicity was assessed (Fig. 5A).",
            "startOffset": 27101,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 30287,
            "parents": [],
            "refoffsets": {
                "bib0335": {
                    "endOffset": 30286,
                    "startOffset": 30282
                }
            },
            "secId": "sec0070",
            "sentence": "In contrast, when we compare this to previously published data using aerosol challenge, the same high challenge dose (880 CFU) was not as virulent and resulted in a 106 CFU lung load, 4 weeks post infection [28].",
            "startOffset": 30075,
            "title": "Discussion"
        },
        {
            "endOffset": 35538,
            "parents": [],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 35371,
                    "startOffset": 35367
                }
            },
            "secId": "sec0070",
            "sentence": "A recent study using ChAdOx1.85A was very immunogenic in cattle [25]; it would therefore be interesting to see whether this can be improved further with MVA85A and more importantly whether this also correlates with protective efficacy.",
            "startOffset": 35303,
            "title": "Discussion"
        },
        {
            "endOffset": 25501,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0060",
            "sentence": "To evaluate the protective efficacy of different vaccination regimes, two duplicate challenge experiments were set up.",
            "startOffset": 25383,
            "title": "Optimisation of vaccine regime: protection studies"
        },
        {
            "endOffset": 23937,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "Based on the above data we decided to proceed with the 4 week interval between ChAdOx.85A and MVA85A.",
            "startOffset": 23836,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 23268,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "In the lungs, there was a significantly higher number of CD4+ IFN\u03b3 producing cells in the 2 compared to the 8 week interval (p < 0.05) (Fig. 2B).",
            "startOffset": 23123,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 26474,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0060",
            "sentence": "In the spleen, all groups that were primed with BCG had lower CFU compared to na\u00efve and non-BCG primed animals but none of the groups had lower bacteria compared to the BCG group (Fig. 4C).",
            "startOffset": 26285,
            "title": "Optimisation of vaccine regime: protection studies"
        },
        {
            "endOffset": 33884,
            "parents": [],
            "secId": "sec0070",
            "sentence": "A likely explanation for the absence of protection is that the slightly higher BCG protective efficacy obtained in the repeat experiment, which approached two log 10 CFU, improvement compared to na\u00efve mice minimised the potential to observe a further improvement in efficacy by additional vaccinations.",
            "startOffset": 33582,
            "title": "Discussion"
        },
        {
            "endOffset": 20419,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Initially, cells were stained for 10 min with live/dead fixable dead cell stain (Invitrogen, UK) followed by surface staining with anti-CD45R/B220, TCR\u03b1\u03b2, TCR\u03b3\u03b4, CD4 and CD8 (eBioscience).",
            "startOffset": 20231,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 21199,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 21198,
                    "startOffset": 21194
                }
            },
            "secId": "sec0045",
            "sentence": "A replication-deficient chimpanzee adenovirus previously developed in Oxford was modified to express Ag85A [25].",
            "startOffset": 21087,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 34281,
            "parents": [],
            "secId": "sec0070",
            "sentence": "Further experiments, will address the ability of B\u2013C\u2013M to induce antigen specific memory responses and to provide durable protection when mice are challenged much later after vaccination.",
            "startOffset": 34094,
            "title": "Discussion"
        },
        {
            "endOffset": 17992,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "All procedures were performed in accordance with the UK Animals (Scientific Procedures) Act 1986 under project licence number 30/2889 granted by the UK Home Office.",
            "startOffset": 17828,
            "title": "Vaccinations"
        },
        {
            "endOffset": 30854,
            "parents": [],
            "refoffsets": {
                "bib0350": {
                    "endOffset": 30853,
                    "startOffset": 30849
                }
            },
            "secId": "sec0070",
            "sentence": "When AdHu5.Ag85A was used to boost BCG-vaccinated guinea pigs, there was no reduction in the bacterial load compared to BCG-vaccinated animals [31].",
            "startOffset": 30706,
            "title": "Discussion"
        },
        {
            "endOffset": 18177,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 18176,
                    "startOffset": 18169
                },
                "bib0320": {
                    "endOffset": 18176,
                    "startOffset": 18169
                }
            },
            "secId": "sec0015",
            "sentence": "Development of E1\u2013E3 deleted replication deficient AdHu5 and ChAdOx1 [18] to express codon-optimised Ag85A antigen from Mycobacterium tuberculosis has been previously described [18,25].",
            "startOffset": 17992,
            "title": "Vaccinations"
        },
        {
            "endOffset": 31899,
            "parents": [],
            "secId": "sec0070",
            "sentence": "One significant limitation of homologous prime-boost vaccination regimens with the same viral vector is the induction of anti-vector immunity induced after the primary vaccination.",
            "startOffset": 31719,
            "title": "Discussion"
        },
        {
            "endOffset": 16386,
            "parents": [],
            "refoffsets": {
                "bib0260": {
                    "endOffset": 16385,
                    "startOffset": 16381
                }
            },
            "secId": "sec0005",
            "sentence": "In addition, human adenovirus type 5 expressing Ag85A; AdHu5.85A, is at earlier stages of clinical testing and completed a phase I study [13].",
            "startOffset": 16244,
            "title": "Introduction"
        },
        {
            "endOffset": 19563,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Plates were incubated at 37 \u00b0C and counted three weeks later.",
            "startOffset": 19502,
            "title": "Quantification of CFU"
        },
        {
            "endOffset": 28676,
            "parents": [],
            "secId": "sec0070",
            "sentence": "One vaccination approach is the use of replication-deficient viral vectors.",
            "startOffset": 28601,
            "title": "Discussion"
        },
        {
            "endOffset": 25328,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "Additional data for Fig. 3, showing different cytokines secreted by CD4+ and CD8+ cells in lung (A and B) and spleen (C and D).",
            "startOffset": 25201,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 24393,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "Four weeks after the last immunisation, lung and spleen responses were evaluated using ICS assay (Fig. 3A).",
            "startOffset": 24286,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 27355,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "In addition, C\u2013Mi.d.",
            "startOffset": 27335,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 17827,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Six to eight week old female Balb/c mice were purchased from Harlan, UK.",
            "startOffset": 17755,
            "title": "Vaccinations"
        },
        {
            "endOffset": 20715,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Samples were run on an LSR II flow cytometer and the data was analysed using FlowJo (TreeStar Inc, Ashland, US) and Spice 5.3 (NIAID, US).",
            "startOffset": 20577,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 19501,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Homogenised organs were diluted in PBS and dilutions were plated in Middlebrook 7H10 plates (Sigma\u2013Aldrich), containing OADC (BD Diagnostic Systems).",
            "startOffset": 19352,
            "title": "Quantification of CFU"
        },
        {
            "endOffset": 15914,
            "parents": [],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 15913,
                    "startOffset": 15909
                }
            },
            "secId": "sec0005",
            "sentence": "There are currently seven subunit candidates being evaluated in clinical trials [10].",
            "startOffset": 15829,
            "title": "Introduction"
        },
        {
            "endOffset": 17321,
            "parents": [],
            "refoffsets": {
                "bib0290": {
                    "endOffset": 17320,
                    "startOffset": 17313
                },
                "bib0295": {
                    "endOffset": 17320,
                    "startOffset": 17313
                }
            },
            "secId": "sec0005",
            "sentence": "Unlike human adenoviral vectors, chimpanzee adenoviral vectors are not affected by pre-existing anti-vector immunity caused by previous vector exposure [19,20].",
            "startOffset": 17161,
            "title": "Introduction"
        },
        {
            "endOffset": 22078,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "CD4+ cells secreting cytokines were very low (data not shown).",
            "startOffset": 22016,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 30615,
            "parents": [],
            "refoffsets": {
                "bib0345": {
                    "endOffset": 30614,
                    "startOffset": 30610
                }
            },
            "secId": "sec0070",
            "sentence": "Particle size and deposition have been shown to have an effect on pathogenicity of an organism [30].",
            "startOffset": 30515,
            "title": "Discussion"
        },
        {
            "endOffset": 19857,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Lungs were perfused with PBS, chopped into small pieces, and digested in DNase/collagenase (Sigma).",
            "startOffset": 19758,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 29377,
            "parents": [],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 29376,
                    "startOffset": 29372
                }
            },
            "secId": "sec0070",
            "sentence": "In mice AdHu5.85A has previously shown superior CD8+ immunogenicity to ChAdOx1.85A, when administered intramuscularly (only in high doses) [25].",
            "startOffset": 29233,
            "title": "Discussion"
        },
        {
            "endOffset": 33517,
            "parents": [],
            "secId": "sec0070",
            "sentence": "significantly improved BCG; although the B\u2013C\u2013Mi.n.",
            "startOffset": 33467,
            "title": "Discussion"
        },
        {
            "endOffset": 22259,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "Four weeks after ChAdOx1.85A administration, mice were challenged with M.tb via the aerosol route and harvested four weeks later for lung and spleen bacterial enumeration (Fig. 1A).",
            "startOffset": 22078,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 28132,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "BCG followed by ChAdOx1.85A was significantly better at inducing IFN\u03b3 CD8+ cells in the lung when compared to na\u00efve and BCG-vaccinated mice.",
            "startOffset": 27992,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 21324,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0325": {
                    "endOffset": 21269,
                    "startOffset": 21265
                }
            },
            "secId": "sec0045",
            "sentence": "As mice have no pre-existing immunity to chimpanzee adenoviruses [26], they were used to assess ChAdOx1.85A vaccine potency.",
            "startOffset": 21200,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 29100,
            "parents": [],
            "secId": "sec0070",
            "sentence": "However, it resulted in no or small reduction in the bacterial load of vaccinated animals (Figs. 1 and 4B\u2013E).",
            "startOffset": 28991,
            "title": "Discussion"
        },
        {
            "endOffset": 15154,
            "parents": [],
            "refoffsets": {
                "bib0200": {
                    "endOffset": 15153,
                    "startOffset": 15150
                }
            },
            "secId": "sec0005",
            "sentence": "Tuberculosis is a global health problem, with an estimated 9 million new cases and 1.5 million deaths in 2013 [1].",
            "startOffset": 15040,
            "title": "Introduction"
        },
        {
            "endOffset": 17718,
            "parents": [],
            "secId": "sec0005",
            "sentence": "We used ChAdOx1, modified to express 85A, ChAdOx1.85A, alone and in combination with MVA85A to optimise both immunogenicity and protective efficacy.",
            "startOffset": 17570,
            "title": "Introduction"
        },
        {
            "endOffset": 18934,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Animals were loaded in nose-only restrainers and exposed to aerosolised M.tb Erdman K01 (TMC107) (BEI resources; Manassas USA), prepared at 1 \u00d7 106 CFU/ml in the nebuliser.",
            "startOffset": 18762,
            "title": "Challenge experiments"
        },
        {
            "endOffset": 29585,
            "parents": [],
            "secId": "sec0070",
            "sentence": "In contrast, there was no difference in protective efficacy when we directly compared i.n. vaccination with our AdHu5.85A versus ChAdOx1.85A, followed by aerosol M.tb challenge (supplementary data Figure 2).",
            "startOffset": 29378,
            "title": "Discussion"
        },
        {
            "endOffset": 24678,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "The M\u2013C regimen was optimal at inducing CD4+ IFN\u03b3 and TNF\u03b1 and the C\u2013C and C\u2013M regimen was optimal for the induction of CD8+ IFN\u03b3 and TNF\u03b1 (Fig. 3B and C for IFN\u03b3 and supplementary Figure 1A and B for all cytokines).",
            "startOffset": 24462,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 28248,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "A further boost with MVA85A failed to enhance IFN\u03b3 production but i.d. MVA85A enhanced both TNF\u03b1 and IL2 responses.",
            "startOffset": 28133,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 15624,
            "parents": [],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 15573,
                    "startOffset": 15570
                },
                "bib0220": {
                    "endOffset": 15623,
                    "startOffset": 15620
                }
            },
            "secId": "sec0005",
            "sentence": "There two live vaccines currently in clinical trials, a recombinant BCG (rBCG VPM1002) [4] and a double deletion mutant of M.tb (MTBVAC) [5].",
            "startOffset": 15483,
            "title": "Introduction"
        },
        {
            "endOffset": 25179,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "Supplementary Figure 1 related to this article can be found, in the online version, at http://dx.doi.org/10.1016/j.vaccine.2015.10.017.",
            "startOffset": 25044,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 23562,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "The populations of cytokine-secreting cells were mainly single or double cytokine producers for both CD4+ and CD8+ T cells (Fig. 2D and E).",
            "startOffset": 23423,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 16872,
            "parents": [],
            "refoffsets": {
                "bib0270": {
                    "endOffset": 16871,
                    "startOffset": 16864
                },
                "bib0275": {
                    "endOffset": 16871,
                    "startOffset": 16864
                }
            },
            "secId": "sec0005",
            "sentence": "AdHu5.85A and MVA85A have both been shown to be more protective when administered by the intranasal compared to the systemic route in mice [15,16].",
            "startOffset": 16725,
            "title": "Introduction"
        },
        {
            "endOffset": 27754,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "In a parallel immunogenicity experiment, Ag85A specific CD4 and CD8 cytokine responses were measured in lungs and spleen, four weeks after the last immunisation.",
            "startOffset": 27593,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 33387,
            "parents": [],
            "secId": "sec0070",
            "sentence": "B\u2013C\u2013Mi.n.",
            "startOffset": 33378,
            "title": "Discussion"
        },
        {
            "endOffset": 24944,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "C alone induced the strongest systemic CD8+ IFN\u03b3 and TNF\u03b1 responses; C\u2013M and C\u2013C also induced good CD8+ responses (Fig. 3D and E for IFN\u03b3 and supplementary Figure 1C and D for all cytokines).",
            "startOffset": 24753,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 20040,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Cells were stimulated with 2 \u03bcg/ml of each Ag85A peptide in a pool of 66 peptides spanning the whole sequence (or media only for unstimulated controls) and incubated for 2 h at 37 \u00b0C.",
            "startOffset": 19857,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 19117,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Mice were infected with 50\u2013100 CFU, verified 24 h after challenge in two mice/experiment.",
            "startOffset": 19028,
            "title": "Challenge experiments"
        },
        {
            "endOffset": 34093,
            "parents": [],
            "secId": "sec0070",
            "sentence": "Although the immune responses measured in these experiments did not correlate with protective efficacy, further work will aim to identify potential correlates of protection that are unique to the B\u2013C\u2013M regime.",
            "startOffset": 33884,
            "title": "Discussion"
        },
        {
            "endOffset": 27473,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "significantly improved the protective efficacy of BCG (p = 0.05 in the lungs and p = 0.002 in spleen) whereas C\u2013Mi.n.",
            "startOffset": 27356,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 23123,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "One week after the MVA85A vaccination, BAL, lung and spleen were collected from each mouse to measure Th1 immune responses (Fig. 2A).",
            "startOffset": 22990,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 21488,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "After a single intranasal immunisation with ChAdOx1.85A, lungs and spleens were harvested four weeks later to evaluate antigen-specific immune responses (Fig. 1A).",
            "startOffset": 21325,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 31564,
            "parents": [],
            "secId": "sec0070",
            "sentence": "(A) Some mice were harvested 24 h post infection to measure infection levels.",
            "startOffset": 31487,
            "title": "Discussion"
        },
        {
            "endOffset": 15828,
            "parents": [],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 15807,
                    "startOffset": 15802
                },
                "bib0230": {
                    "endOffset": 15807,
                    "startOffset": 15802
                },
                "bib0235": {
                    "endOffset": 15807,
                    "startOffset": 15802
                },
                "bib0240": {
                    "endOffset": 15807,
                    "startOffset": 15802
                }
            },
            "secId": "sec0005",
            "sentence": "Subunit vaccine antigens are delivered as either adjuvanted protein [6\u20139] or in viral vectors.",
            "startOffset": 15734,
            "title": "Introduction"
        },
        {
            "endOffset": 16724,
            "parents": [],
            "refoffsets": {
                "bib0265": {
                    "endOffset": 16723,
                    "startOffset": 16719
                }
            },
            "secId": "sec0005",
            "sentence": "Induction of lung immune responses by vaccination could potentially prevent the establishment of infection [14].",
            "startOffset": 16612,
            "title": "Introduction"
        },
        {
            "endOffset": 17569,
            "parents": [],
            "refoffsets": {
                "bib0280": {
                    "endOffset": 17489,
                    "startOffset": 17482
                },
                "bib0310": {
                    "endOffset": 17489,
                    "startOffset": 17482
                },
                "bib0315": {
                    "endOffset": 17568,
                    "startOffset": 17564
                }
            },
            "secId": "sec0005",
            "sentence": "MVA85A induces primarily CD4+ T cell responses [17,23] and recombinant adenoviral vectors induce primarily CD8+ T cell responses [24].",
            "startOffset": 17435,
            "title": "Introduction"
        },
        {
            "endOffset": 23422,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "CD8+ responses were significantly higher in the 2 week compared to the 8 week interval for IFN\u03b3 (p < 0.01), TNF\u03b1 (p < 0.01) and IL2 (p < 0.01) (Fig. 2C).",
            "startOffset": 23269,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 25044,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "Mice that received ChAdOx1.85A (C\u2013M, C\u2013C and C) all had TCR\u03b3\u03b4 IL17 responses in the lung (Fig. 3F).",
            "startOffset": 24945,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 28600,
            "parents": [],
            "secId": "sec0070",
            "sentence": "BCG is not effective against pulmonary TB, and subunit vaccines designed to boost its immunity and protective efficacy are required.",
            "startOffset": 28468,
            "title": "Discussion"
        },
        {
            "endOffset": 34694,
            "parents": [],
            "refoffsets": {
                "bib0385": {
                    "endOffset": 34489,
                    "startOffset": 34485
                }
            },
            "secId": "sec0070",
            "sentence": "ChAdOx1 expressing influenza A antigens was safe and immunogenic in clinical trials [38] and ChAdOx1.85A, currently being evaluated in a phase I first-time-in-man study is also showing good safety and immunogenicity (McShane, personal communication), making this a promising vaccine candidate.",
            "startOffset": 34401,
            "title": "Discussion"
        },
        {
            "endOffset": 20576,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Following permeabilisation using CytoFix/CytoPerm (BD Biosciences), cells were stained intracellularly with anti-IFN-\u03b3, TNF-\u03b1, IL-2 and IL-17 (eBioscience).",
            "startOffset": 20420,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 21013,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Analysis of two data sets was performed using Mann\u2013Whitney or Kruskal\u2013Wallis (non-parametric) or one-way Anova followed by post hoc tests for comparing three or more groups.",
            "startOffset": 20840,
            "title": "Statistical analyses and presentation"
        },
        {
            "endOffset": 33531,
            "parents": [],
            "secId": "sec0070",
            "sentence": "and B\u2013C\u2013Mi.d.",
            "startOffset": 33518,
            "title": "Discussion"
        },
        {
            "endOffset": 18761,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Mice were challenged using a Biaera AeroMP-controlled nebuliser (Biera technologies; Hagerstown, USA) contained in a Biosafety level 3 TCOL isolator.",
            "startOffset": 18612,
            "title": "Challenge experiments"
        },
        {
            "endOffset": 24070,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "We then optimised a vaccination regime based on the two viral vectors.",
            "startOffset": 24000,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 22624,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "BCG-vaccinated animals had significantly lower bacterial load compared to unvaccinated mice (reduced by 1.46 log10 in lung, p < 0.001 and 1.57 log10 in spleen, p < 0.001) whereas ChAdOx1.85A only slightly decreased the bacterial load of vaccinated compared to unvaccinated mice in the lung (0.32 log10, p = 0.047,) and spleen (0.2 log10, p = 0.08) (Fig. 1E and F).",
            "startOffset": 22260,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 31135,
            "parents": [],
            "secId": "sec0070",
            "sentence": "(A) Lung and (B) spleen CFU data.",
            "startOffset": 31102,
            "title": "Discussion"
        },
        {
            "endOffset": 33466,
            "parents": [],
            "secId": "sec0070",
            "sentence": "were directly compared in a challenge experiment, only B\u2013C\u2013Mi.d.",
            "startOffset": 33402,
            "title": "Discussion"
        },
        {
            "endOffset": 15733,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Subunit vaccines are administered after BCG and focus immunity to a single or a few immunodominant antigens.",
            "startOffset": 15625,
            "title": "Introduction"
        },
        {
            "endOffset": 23836,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "There were no differences in the number of cytokine secreting CD4+ or CD8+ cells in the BAL between groups (Fig. 2F and G), whereas spleen responses were lower than the BAL and lung responses, with the 4 week interval inducing stronger CD8+ IFN\u03b3 responses (data not shown).",
            "startOffset": 23563,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 31719,
            "parents": [],
            "secId": "sec0070",
            "sentence": "(B) Lung bacterial load 4 weeks after infection (the group challenged with 5 \u00d7 107 CFU/ml in the nebuliser had to be culled before the 4 week time point).",
            "startOffset": 31565,
            "title": "Discussion"
        },
        {
            "endOffset": 22989,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0050",
            "sentence": "To identify the optimal time interval between the two vaccinations, mice were vaccinated i.n. with ChAdOx.85A and boosted i.n. with MVA85A 2, 4 or 8 weeks later.",
            "startOffset": 22828,
            "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
        },
        {
            "endOffset": 27334,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "The BCG-vaccinated group had significantly lower bacterial counts compared to the na\u00efve control group (p < 0.0001).",
            "startOffset": 27219,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 27593,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "approached significance in the lung and was significant in the spleen (p = 0.07 lung, p = 0.05 spleen) (Fig. 5B and C).",
            "startOffset": 27474,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 20839,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Statistical analysis was conducted and graphs were generated using GraphPad Prism 5.",
            "startOffset": 20755,
            "title": "Statistical analyses and presentation"
        },
        {
            "endOffset": 20231,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "The following day intracellular staining was performed.",
            "startOffset": 20176,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 15328,
            "parents": [],
            "refoffsets": {
                "bib0205": {
                    "endOffset": 15327,
                    "startOffset": 15324
                }
            },
            "secId": "sec0005",
            "sentence": "BCG is the only available vaccine, and although protective against disseminated forms of childhood disease, it is not consistently protective against adult pulmonary TB [2].",
            "startOffset": 15155,
            "title": "Introduction"
        },
        {
            "endOffset": 31359,
            "parents": [],
            "secId": "sec0070",
            "sentence": "A group of mice was vaccinated i.d. with BCG and challenged 6 weeks later; in parallel, one group of mice received AdHu5.85A and another group ChAdOx1.85A, both i.n. and challenged four weeks later with aerosol M.tb Erdman.",
            "startOffset": 31136,
            "title": "Discussion"
        },
        {
            "endOffset": 33186,
            "parents": [],
            "secId": "sec0070",
            "sentence": "When C\u2013M and M\u2013C were administered i.n. (Fig. 4D) they were able reduce the bacterial load compared to unvaccinated mice, however only the C\u2013M regimen was able to significantly improve BCG efficacy (Figs. 4B, D and E and 5B and C), whichever the route of MVA85A.",
            "startOffset": 32924,
            "title": "Discussion"
        },
        {
            "endOffset": 34401,
            "parents": [],
            "refoffsets": {
                "bib0380": {
                    "endOffset": 34400,
                    "startOffset": 34396
                }
            },
            "secId": "sec0070",
            "sentence": "In addition, the distribution of antigen-specific T cells in different lung compartments will be further explored [37].",
            "startOffset": 34282,
            "title": "Discussion"
        },
        {
            "endOffset": 27864,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "ICS was used to quantify and compare the percentage of cytokine secreting CD4+ and CD8+ cells between groups.",
            "startOffset": 27755,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 18312,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Mice were vaccinated with a dose of 1 \u00d7 108 infectious units (ifu) of ChAdOx1.85A and/or 5 \u00d7 106 plaque forming units (pfu) of MVA85A.",
            "startOffset": 18178,
            "title": "Vaccinations"
        },
        {
            "endOffset": 28375,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "Boosting with ChAdOx1.85A and MVA85A increased the double cytokine secreting CD4+ and CD8+ cells in the lungs (Fig. 5F and G).",
            "startOffset": 28249,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 31486,
            "parents": [],
            "secId": "sec0070",
            "sentence": "Mycobacterial dose escalation challenge experiment.",
            "startOffset": 31435,
            "title": "Discussion"
        },
        {
            "endOffset": 33401,
            "parents": [],
            "secId": "sec0070",
            "sentence": "and B\u2013C\u2013Mi.d.",
            "startOffset": 33388,
            "title": "Discussion"
        },
        {
            "endOffset": 26284,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0060",
            "sentence": "The B\u2013C\u2013M vaccinated mice had significantly lower lung CFU than all the other BCG primed groups (p < 0.01) apart from B\u2013M\u2013C (which was not significantly better when compared to BCG).",
            "startOffset": 26102,
            "title": "Optimisation of vaccine regime: protection studies"
        },
        {
            "endOffset": 17032,
            "parents": [],
            "refoffsets": {
                "bib0280": {
                    "endOffset": 17031,
                    "startOffset": 17027
                }
            },
            "secId": "sec0005",
            "sentence": "In addition, MVA85A administered by aerosol in BCG-vaccinated healthy adults, was well tolerated and induced strong mucosal and systemic immune responses [17].",
            "startOffset": 16873,
            "title": "Introduction"
        },
        {
            "endOffset": 17160,
            "parents": [],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 17159,
                    "startOffset": 17155
                }
            },
            "secId": "sec0005",
            "sentence": "In this pre-clinical study we have used a replication-deficient chimpanzee adenovirus vector developed in Oxford (ChAdOx1) [18].",
            "startOffset": 17032,
            "title": "Introduction"
        },
        {
            "endOffset": 28457,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "In the spleen, BCG-C\u2013M i.d. induced the strongest CD8+ T cell response (Fig. 5I).",
            "startOffset": 28376,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 16053,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Recombinant viral vectors represent a highly potent antigen delivery system and several are currently being evaluated in TB vaccine trials.",
            "startOffset": 15914,
            "title": "Introduction"
        },
        {
            "endOffset": 18502,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "BCG Pasteur was grown in-house in 7H9 Broth (BD, UK) containing 0.05% Tween 80.",
            "startOffset": 18423,
            "title": "Vaccinations"
        },
        {
            "endOffset": 30074,
            "parents": [],
            "secId": "sec0070",
            "sentence": "An infection with approximately 8 CFU, measured 24 h post infection, resulted in 106 CFU in the lungs of infected mice at 4 weeks post infection and a dose of 800 CFU at 24 h post infection (supplementary data Figure 3A) lead to 109 CFU in the lungs and mice succumbing to disease at day 24, 4 days before the scheduled 4 week time point (supplementary data Figure 3B).",
            "startOffset": 29705,
            "title": "Discussion"
        },
        {
            "endOffset": 35089,
            "parents": [],
            "refoffsets": {
                "bib0390": {
                    "endOffset": 35088,
                    "startOffset": 35084
                }
            },
            "secId": "sec0070",
            "sentence": "In the malaria field, in a clinical challenge study, heterologous prime boost with ChAd63 followed by MVA, both expressing METRAP, conferred 21% efficacy, in contrast to control volunteers and individuals vaccinated with ChAd63-METRAP, who all developed malaria [39].",
            "startOffset": 34822,
            "title": "Discussion"
        },
        {
            "endOffset": 19027,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "The programme was run for 10 min (plus 5 min purge), airflow 12 L/min, and pressure 20 psig.",
            "startOffset": 18935,
            "title": "Challenge experiments"
        },
        {
            "endOffset": 29704,
            "parents": [],
            "secId": "sec0070",
            "sentence": "The reason for this discrepancy is not clear but a possible explanation is that our infection model is more stringent.",
            "startOffset": 29586,
            "title": "Discussion"
        },
        {
            "endOffset": 20175,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Golgi plug (1 \u03bcl/ml) (BD Biosciences) was added in each well and incubated for a further 4 h followed by incubation overnight at 4 \u00b0C.",
            "startOffset": 20041,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 29232,
            "parents": [],
            "refoffsets": {
                "bib0270": {
                    "endOffset": 29231,
                    "startOffset": 29224
                },
                "bib0330": {
                    "endOffset": 29231,
                    "startOffset": 29224
                }
            },
            "secId": "sec0070",
            "sentence": "This absence of protection is in contrast to the intranasal administration of human adenovirus expressing the same antigen [15,27].",
            "startOffset": 29101,
            "title": "Discussion"
        },
        {
            "endOffset": 24188,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "Balb/c mice were either homologously or heterologously boosted with ChAdOx1.85A (C) or MVA85A (M) via the i.n. route.",
            "startOffset": 24071,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 34821,
            "parents": [],
            "secId": "sec0070",
            "sentence": "This study suggests that a further boost with MVA85A could potentially improve its immunogenicity and its protective efficacy.",
            "startOffset": 34695,
            "title": "Discussion"
        },
        {
            "endOffset": 19757,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "BAL fluid was obtained by three successive lung lavages with 0.5 ml of 10 mM EDTA/PBS (Sigma).",
            "startOffset": 19663,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 32444,
            "parents": [],
            "refoffsets": {
                "bib0360": {
                    "endOffset": 32443,
                    "startOffset": 32436
                },
                "bib0365": {
                    "endOffset": 32443,
                    "startOffset": 32436
                }
            },
            "secId": "sec0070",
            "sentence": "A simian adenoviral vector, ChAd63, expressing malaria antigens, followed by MVA expressing the same malaria antigens, induced strong immune responses that were higher than those induced by one vector alone in clinical trials [33,34].",
            "startOffset": 32210,
            "title": "Discussion"
        },
        {
            "endOffset": 16243,
            "parents": [],
            "refoffsets": {
                "bib0250": {
                    "endOffset": 16162,
                    "startOffset": 16158
                },
                "bib0255": {
                    "endOffset": 16242,
                    "startOffset": 16238
                }
            },
            "secId": "sec0005",
            "sentence": "The most advanced are the replication-deficient modified Vaccinia virus Ankara expressing Ag85A; MVA85A [11], and human adenovirus, AdHu35 expressing Ag85A, Ag85B and TB10.4; Aeras402 [12].",
            "startOffset": 16054,
            "title": "Introduction"
        },
        {
            "endOffset": 24285,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "Three control groups ChAdOx1.85A i.n. alone, MVA85A i.n. alone and BCG i.d. alone were included.",
            "startOffset": 24189,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 18588,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Mice were vaccinated with 4 \u00d7 105 colony forming units (CFU)/dose via the i.d. route.",
            "startOffset": 18503,
            "title": "Vaccinations"
        },
        {
            "endOffset": 18423,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Vaccinations were performed via the intradermal (i.d.) or intranasal (i.n.) route, in a final volume of 50 \u03bcl.",
            "startOffset": 18313,
            "title": "Vaccinations"
        },
        {
            "endOffset": 19351,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Organs were homogenised in re-inforced tubes with ceramic beads containing 1 ml PBS using Precellys 24 (Stretton Scientific, UK).",
            "startOffset": 19222,
            "title": "Quantification of CFU"
        },
        {
            "endOffset": 24461,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0055",
            "sentence": "All regimes were able to induce CD4+ and CD8+ T cells in the lungs.",
            "startOffset": 24394,
            "title": "Optimisation of vaccination regime: immunogenicity studies"
        },
        {
            "endOffset": 30996,
            "parents": [],
            "secId": "sec0070",
            "sentence": "Supplementary Figures 2 and 3 related to this article can be found, in the online version, at http://dx.doi.org/10.1016/j.vaccine.2015.10.017.",
            "startOffset": 30854,
            "title": "Discussion"
        },
        {
            "endOffset": 25890,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0060",
            "sentence": "Mice were challenged with aerosolised M.tb four weeks after the last immunisation and lung and spleen harvested four weeks later for CFU enumeration (Fig. 4A).",
            "startOffset": 25731,
            "title": "Optimisation of vaccine regime: protection studies"
        },
        {
            "endOffset": 19221,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Lungs and spleens of infected animals were harvested four weeks after challenge.",
            "startOffset": 19141,
            "title": "Quantification of CFU"
        },
        {
            "endOffset": 26872,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0060",
            "sentence": "When the experiment was repeated with MVA85A administered i.n., C\u2013M, M\u2013C and C vaccinated mice had lower bacteria in the lungs (p < 0.05) when compared to unvaccinated mice but only C\u2013M vaccination significantly reduced the CFU in the spleen (p < 0.05); BCG-primed mice had significantly lower load in both the lung and spleen if they were boosted with C\u2013M (B\u2013C\u2013M group) (p < 0.05) (Fig. 4D and E).",
            "startOffset": 26474,
            "title": "Optimisation of vaccine regime: protection studies"
        },
        {
            "endOffset": 19662,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Cells were extracted from the bronchoalveolar lavage (BAL) fluid, lung and spleen.",
            "startOffset": 19580,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 25730,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                },
                {
                    "id": "sec0050",
                    "title": "Boosting ChAdOx1.85A with MVA85A, optimising the time interval"
                }
            ],
            "secId": "sec0060",
            "sentence": "In one experiment Balb/c mice received ChAdOx1.85A i.n. and MVA85A i.d. 4 weeks later (with and without BCG prime); and in the second experiment the MVA85A boost was administered i.n. with the same interval between vaccinations.",
            "startOffset": 25502,
            "title": "Optimisation of vaccine regime: protection studies"
        },
        {
            "endOffset": 32209,
            "parents": [],
            "secId": "sec0070",
            "sentence": "For this reason, heterologous prime-boost immunisations with viral vectors are more promising.",
            "startOffset": 32115,
            "title": "Discussion"
        },
        {
            "endOffset": 31101,
            "parents": [],
            "secId": "sec0070",
            "sentence": "Challenge results after a single intranasal administration of 1 \u00d7 108 ifu of virus.",
            "startOffset": 31018,
            "title": "Discussion"
        },
        {
            "endOffset": 27991,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "All BCG boosting vaccines induced stronger CD8+ than CD4+ T cells in both the lung (Fig. 5D and E) and spleen (Fig. 5H and I).",
            "startOffset": 27865,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 21722,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "In the lungs, ChAdOx1.85A induced a significant frequency of Ag85A-specific CD8+ T cells secreting IFN\u03b3 compared to na\u00efve mice (p < 0.05) and higher TNF\u03b1 and IL17 compared to both na\u00efve and BCG-vaccinated groups (p < 0.05) (Fig. 1B).",
            "startOffset": 21489,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 32923,
            "parents": [],
            "refoffsets": {
                "bib0365": {
                    "endOffset": 32922,
                    "startOffset": 32918
                }
            },
            "secId": "sec0070",
            "sentence": "Even though the level of immune response was similar between those groups it is possible that the breadth of the immune response differs and this is worth investigating further [34].",
            "startOffset": 32741,
            "title": "Discussion"
        },
        {
            "endOffset": 32740,
            "parents": [],
            "secId": "sec0070",
            "sentence": "Surprisingly, boosting ChAdOx1.85A with MVA85A did not induce stronger IFN\u03b3 when compared to ChAdOx1.85A followed by ChAdOx1.85A or to ChAdOx1.85A alone (the median response was higher for the first two), whereas MVA85A followed by ChAdOx1.85A was better than MVA85A followed by MVA85A (Fig. 3).",
            "startOffset": 32445,
            "title": "Discussion"
        },
        {
            "endOffset": 27100,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "To directly compare the two most protective regimes, mice were vaccinated with either B\u2013C\u2013M (M administered i.d.) or B\u2013C\u2013M (M administered i.n.).",
            "startOffset": 26955,
            "title": "Immunogenicity and protective efficacy of the most promising vaccination regimes"
        },
        {
            "endOffset": 35302,
            "parents": [],
            "secId": "sec0070",
            "sentence": "ChAdOx1.85A followed by intranasal or intradermal MVA85A as a boost to BCG is a promising vaccination regimen that should be investigated further for protective efficacy in other preclinical M.tb infection models.",
            "startOffset": 35089,
            "title": "Discussion"
        },
        {
            "endOffset": 28831,
            "parents": [],
            "secId": "sec0070",
            "sentence": "These are very immunogenic and have a good safety record as evidenced by a number of clinical trials against TB and a number of other infectious diseases.",
            "startOffset": 28677,
            "title": "Discussion"
        },
        {
            "endOffset": 22015,
            "parents": [
                {
                    "id": "sec0040",
                    "title": "Results"
                }
            ],
            "secId": "sec0045",
            "sentence": "In the spleen, ChAdOx1.85A induced systemic CD8+ cells secreting IFN\u03b3, TNF\u03b1 and IL2 (Fig. 1D).",
            "startOffset": 21921,
            "title": "Construction of ChAdOx1 expressing Ag85A and in vivo assessment"
        },
        {
            "endOffset": 33581,
            "parents": [],
            "secId": "sec0070",
            "sentence": "were not significantly different (Fig. 5B and C).",
            "startOffset": 33532,
            "title": "Discussion"
        },
        {
            "endOffset": 32114,
            "parents": [],
            "refoffsets": {
                "bib0355": {
                    "endOffset": 32113,
                    "startOffset": 32109
                }
            },
            "secId": "sec0070",
            "sentence": "In this study, mucosal homologous boosting of both ChAdOx1.85A and MVA85A (Fig. 3) did not result in improvement in the lung immune responses compared to a single vaccination, in agreement with published data [32].",
            "startOffset": 31900,
            "title": "Discussion"
        },
        {
            "endOffset": 15482,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 15481,
                    "startOffset": 15478
                }
            },
            "secId": "sec0005",
            "sentence": "Vaccine development efforts are focused on either replacing BCG (live vaccines) or identifying \u2018BCG boosting\u2019 vaccines to improve protective immunity [3].",
            "startOffset": 15328,
            "title": "Introduction"
        },
        {
            "endOffset": 17435,
            "parents": [],
            "refoffsets": {
                "bib0300": {
                    "endOffset": 17434,
                    "startOffset": 17427
                },
                "bib0305": {
                    "endOffset": 17434,
                    "startOffset": 17427
                }
            },
            "secId": "sec0005",
            "sentence": "This pre-existing immunity could reduce potency when the vaccine is administered in the human population [21,22].",
            "startOffset": 17322,
            "title": "Introduction"
        },
        {
            "endOffset": 30514,
            "parents": [],
            "refoffsets": {
                "bib0340": {
                    "endOffset": 30513,
                    "startOffset": 30509
                }
            },
            "secId": "sec0070",
            "sentence": "This suggests that our challenge application is particularly efficient, generating small particles, 1\u20132 \u03bcm (which then dry down and become smaller), which can disseminate more efficiently throughout and deep in the lungs [29].",
            "startOffset": 30288,
            "title": "Discussion"
        },
        {
            "endOffset": 31413,
            "parents": [],
            "secId": "sec0070",
            "sentence": "Experiment was terminated four weeks after challenge.",
            "startOffset": 31360,
            "title": "Discussion"
        },
        {
            "endOffset": 28990,
            "parents": [],
            "secId": "sec0070",
            "sentence": "A single intranasal immunisation with ChAdOx1.85A, alone or as a boost to BCG was highly immunogenic, inducing strong immune responses in the lungs and spleen.",
            "startOffset": 28831,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X15014322",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "E.",
                "initial": "E.",
                "last": "Stylianou"
            },
            {
                "email": null,
                "first": "K. L.",
                "initial": "K.L.",
                "last": "Griffiths"
            },
            {
                "email": null,
                "first": "H. C.",
                "initial": "H.C.",
                "last": "Poyntz"
            },
            {
                "email": null,
                "first": "R.",
                "initial": "R.",
                "last": "Harrington-Kandt"
            },
            {
                "email": null,
                "first": "M. D.",
                "initial": "M.D.",
                "last": "Dicks"
            },
            {
                "email": null,
                "first": "L.",
                "initial": "L.",
                "last": "Stockdale"
            },
            {
                "email": null,
                "first": "G.",
                "initial": "G.",
                "last": "Betts"
            },
            {
                "email": "helen.mcshane@ndm.ox.ac.uk",
                "first": "H.",
                "initial": "H.",
                "last": "McShane"
            }
        ],
        "doi": "10.1016/j.vaccine.2015.10.017",
        "firstpage": "6800",
        "issn": "0264410X",
        "keywords": [
            "BCG",
            "Immunogenicity",
            "Intranasal",
            "Protection",
            "Tuberculosis",
            "Vaccine",
            "Viral vector"
        ],
        "lastpage": "6808",
        "openaccess": "Full",
        "pub_year": 2015,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A"
    }
}